Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.7 USD | +3.49% |
|
+13.07% | -25.32% |
07-15 | Morgan Stanley Lowers Price Target on NeuroPace to $8 From $9.50, Keeps Equalweight Rating | MT |
07-01 | NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell Small Cap Completeness Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.32% | 222M | |
+2.62% | 208B | |
+6.44% | 182B | |
+29.61% | 155B | |
+34.96% | 115B | |
+3.84% | 66.52B | |
+17.38% | 53.93B | |
-4.51% | 46.26B | |
-5.77% | 38.22B | |
+3.71% | 36.6B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- Transcript : NeuroPace, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-12-2023 09